StockUnited StatesNasdaqCM

BLTE

Belite Bio, Inc

Healthcare · Biotechnology

183.16USD

-9.6900 (-5.02%)

Description Historical Financials Relative Value Research News Discussion OptionsPrice Chart ↗Fundamental Chart ↗

Fiscal Year End12/2025

Last Quarter End06/2026 Q2

Current/T12M(USD)

Issue Data

Last PxUSD / 183.16

P/E—

Dvd Ind Yld—

P/B10.00

P/S—

Curr EV/T12M EBITDA—

Mkt Cap (USD)7.8B

Curr EV (USD)—

Per Share Data

EPS T12M-2.73

DPS—

Bk Val Per Sh19.29

Rev/Sh—

Cash/Sh8.78

Curr Shares Out40.3M

FCF/Sh-0.92

Cash Flow Analysis

P/CF-210.0

Curr P/FCF-209.0

CF/NI0.4

Dvd P/O0.0%

Cash Gen/Cash Reqd—

Csh Dvd Cov—

CFO/Sales—

Eff Interest Rate—

Growth Potential

Dil EPS 1Y Gr-95.8%

Cap 1Y Gr428.4%

BPS 1Y Gr381.1%

R&D To Sales—

Retention Rate100.0%

Rev 1Y Gr—

FCF 1Y Gr-26.5%

Assets 1Y Gr413.1%

Profitability

EBITDA-0.1B

EBIT-0.1B

Operating Margin0.0%

Pretax Margin—

Net Margin0.0%

ROA-21.6%

ROE-22.1%

ROC—

Asset Turnover—

Structure

Current Ratio50.76

Quick Ratio—

Debt/Assets0.0%

Debt/Com Eq0.0%

Net Debt/EBITDA4.21

Tot Debt/Capital0.0%

Gross Margin0.0%

EBIT/Int Exp-59,343.0

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.

Reading financial statements from SEC filings…

A first visit to a security takes a few seconds.